Skip to main content

C50.611 vs C50.619

C50.611 (Malignant neoplasm of axillary tail of right female breast) compared with C50.619 (Malignant neoplasm of axillary tail of unspecified female breast), from the official CMS tabular data. C50.611 and C50.619 code the same condition on opposite sides. MedCoder-derived

Relationship

Review

Laterality relationship

C50.611
Right
Malignant neoplasm of axillary tail of right female breast
C50.619
Unspecified
Malignant neoplasm of axillary tail of unspecified female breast

Same condition; these differ only in which side is documented.

These codes share a category and title and differ only in the side affected. The documentation decides which applies, and a bilateral code is reported only where the code set provides one.

Source: ICD-10-CM tabular list (laterality variant derived from the code title)

Can these codes be reported together?

Same condition, opposite side. C50.611 and C50.619 name the same condition on opposite sides of the body.

Same category and title, differing only in which side is affected — the documentation decides which one applies, and a bilateral code is reported only where the code set provides one.

Side by side

C50.611Malignant neoplasm of axillary tail of right female breastC50.619Malignant neoplasm of axillary tail of unspecified female breast
Billing statusBillableBillable
ClassificationC00-D49 — NeoplasmsC00-D49 — Neoplasms
DefinitionMalignant neoplasm of axillary tail of right female breast is a billable ICD-10-CM diagnosis code (C50.611).Malignant neoplasm of axillary tail of unspecified female breast is a billable ICD-10-CM diagnosis code (C50.619).
Includes
connective tissue of breast
Paget's disease of breast
Paget's disease of nipple
connective tissue of breast
Paget's disease of breast
Paget's disease of nipple
Use additional code
code to identify estrogen, and other hormones and factors receptor status (Z17.-)
code to identify estrogen, and other hormones and factors receptor status (Z17.-)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources